Gastroenterology

June 10th 2025

Specific protein signatures could predict a future diagnosis of Crohn disease and ulcerative colitis, potentially enabling earlier intervention and improving patient outcomes.

June 2nd 2025

Stem cell transplants could produce promising remission rates for children with severe monogenic inflammatory bowel disease (IBD), transforming treatment options.

May 23rd 2025

Guselkumab shows significant clinical and endoscopic benefits for adults with moderate to severe Crohn disease, offering a promising treatment alternative.

May 12th 2025

Upadacitinib shows sustained efficacy and consistent safety for moderate to severe ulcerative colitis in long-term trials and real-world data, with findings reinforced by new results presented at Digestive Disease Week 2025.